Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

Author:

Saad-Roy Chadi M.1ORCID,Wagner Caroline E.234ORCID,Baker Rachel E.23ORCID,Morris Sinead E.5ORCID,Farrar Jeremy6ORCID,Graham Andrea L.2ORCID,Levin Simon A.2ORCID,Mina Michael J.7ORCID,Metcalf C. Jessica E.28ORCID,Grenfell Bryan T.289ORCID

Affiliation:

1. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA.

2. Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.

3. Princeton Environmental Institute, Princeton University, Princeton, NJ 08544, USA.

4. Department of Bioengineering, McGill University, Montreal, Quebec H3A 0C3, Canada.

5. Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.

6. Wellcome Trust, London, UK.

7. Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.

8. Princeton School of Public and International Affairs, Princeton University, Princeton, NJ 08544, USA.

9. Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.

Abstract

Imperfect future immunity Humans are infected by several seasonal and cross-reacting coronaviruses. None provokes fully protective immunity, and repeat infections are the norm. Vaccines tend to be less efficient than natural infections at provoking immunity, and there are risks of adverse cross-reactions. Saad-Roy et al. used a series of simple models for a variety of immune scenarios to envisage immunological futures for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without vaccines. The model outcomes show that our imperfect knowledge about the imperfect coronavirus immune landscape can give rise to diverging scenarios ranging from recurring severe epidemics to elimination. It is critical that we accurately characterize immune responses to SARS-CoV-2 for translation into managing disease control. Science , this issue p. 811

Funder

National Science Foundation

Centers for Disease Control and Prevention

James S. McDonnell Foundation

Life Sciences Research Foundation

Natural Sciences and Engineering Research Council of Canada

C3.ai Digital Transformation Institute

Flu Lab

Cooperative Institute for Modelling the Earth System

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3